444648007: Tocilizumab (substance)

SNOMED CT Concept\Substance\...

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Monoclonal antibody\Tocilizumab (substance)

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Amide and/or amide derivative (substance)\Substituted amide (substance)\Polypeptide\Protein\Antibody\Monoclonal antibody\Tocilizumab (substance)

\Organic compound\Organic nitrogen compound\Amide and/or amide derivative (substance)\Substituted amide (substance)\Polypeptide\Protein\Antibody\Monoclonal antibody\Tocilizumab (substance)

\Biological substance\Protein and/or protein derivative\Protein\Antibody\Monoclonal antibody\Tocilizumab (substance)
\Biological substance\Immunologic substance\Antibody\Monoclonal antibody\Tocilizumab (substance)
\Biological substance\Polypeptide\Protein\Antibody\Monoclonal antibody\Tocilizumab (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2010. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

2870396019 Tocilizumab (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

2870894010 Tocilizumab en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

55991000195113 tocilizumab it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

846521000172119 tocilizumab fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

71101000195116 Tocilizumab de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Tocilizumab (substance)	Is a	agent d'anticorps monoclonal	false	Inferred relationship	Some
Tocilizumab (substance)	Is a	Monoclonal antibody	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Tocilizumab 20mg/mL solution for intravenous infusion	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Tocilizumab (substance)	Inferred relationship	Some
Product containing tocilizumab (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Tocilizumab (substance)	Inferred relationship	Some	1
Tocilizumab therapy (procedure)	Direct substance	True	Tocilizumab (substance)	Inferred relationship	Some	2
Product containing tocilizumab in parenteral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Tocilizumab (substance)	Inferred relationship	Some	1
Tocilizumab 20mg/mL conventional release solution for injection	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Tocilizumab (substance)	Inferred relationship	Some
Product containing only tocilizumab (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Tocilizumab (substance)	Inferred relationship	Some	1
Tocilizumab only product in parenteral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Tocilizumab (substance)	Inferred relationship	Some	1
Product containing precisely tocilizumab 20 milligram/1 milliliter conventional release solution for injection (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Tocilizumab (substance)	Inferred relationship	Some	1
Product containing precisely tocilizumab 20 milligram/1 milliliter conventional release solution for injection (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Tocilizumab (substance)	Inferred relationship	Some	1
Product containing precisely tocilizumab 180 milligram/1 milliliter conventional release solution for injection (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Tocilizumab (substance)	Inferred relationship	Some	1
Product containing precisely tocilizumab 180 milligram/1 milliliter conventional release solution for injection (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Tocilizumab (substance)	Inferred relationship	Some	1
Administration of tocilizumab (procedure)	Direct substance	True	Tocilizumab (substance)	Inferred relationship	Some	1
Adverse reaction to tocilizumab (disorder)	Causative agent (attribute)	True	Tocilizumab (substance)	Inferred relationship	Some	1

This concept is not in any reference sets